Funding
Amounts as reported; USD estimates shown only when they matchListed 1 funding record. Latest funding: $275M (Series F), Sep 9, 2026.
| Date | Amount | Investors | Sources |
|---|---|---|---|
| Sep 9, 2026 | $275M · Series F | ARCH, Braidwell, Illumina Ventures, 软银愿景基金二期 | 1 source Source ↗ |
Evidence Encoded Therapeutics Raises $275M Series F for Gene TherapiesOn September 9, 2026, per Encoded Therapeutics, gene therapy company for neurological disorders closed a $275M Series F co-led by GV and an unnamed healthcare fund, with ARCH, Braidwell, Illumina Ventures and SoftBank Vision Fund 2. The company was co-founded by Kartik Ramamoorthi and Stephanie Tagliatela. Translated source brief, not a quotation. Check the original before citing. Sources · 1
| |||
Select ▸ on a row to see its source brief and links.
Valuation
Amounts as reported; USD estimates shown only when they matchListed 1 valuation record.
No chartable valuation estimates yet.
1 listed record lack a clear date or positive USD estimate for the chart.
| Date | Amount | Investors | Sources |
|---|---|---|---|
| Sep 9, 2026 | — · Series F | ARCH, Braidwell, Illumina Ventures, 软银愿景基金二期 | 1 source Source ↗ |
Evidence Encoded Therapeutics Raises $275M Series F for Gene TherapiesOn September 9, 2026, per Encoded Therapeutics, gene therapy company for neurological disorders closed a $275M Series F co-led by GV and an unnamed healthcare fund, with ARCH, Braidwell, Illumina Ventures and SoftBank Vision Fund 2. The company was co-founded by Kartik Ramamoorthi and Stephanie Tagliatela. Translated source brief, not a quotation. Check the original before citing. Sources · 1
| |||
Select ▸ on a row to see its source brief and links.
Revenue
Amounts as reported; USD estimates shown only when they matchNo revenue records are listed yet.
No revenue rows to list.
Team, products & investors
Sources · 0Sources & provenance
English text is maintained separately from the original record. Consult the original source before citing a fact.
No source links are available for this profile.